Susan L. Mooberry
Department of Physiology and Medicine
Southwest Foundation for Biomedical Research
San Antonio
Texas 78245
USA
Name/email consistency: high
- Function-oriented synthesis: biological evaluation of laulimalide analogues derived from a last step cross metathesis diversification strategy. Mooberry, S.L., Hilinski, M.K., Clark, E.A., Wender, P.A. Mol. Pharm. (2008)
- Identification and characterization of a new tubulin-binding tetrasubstituted brominated pyrrole. Mooberry, S.L., Weiderhold, K.N., Dakshanamurthy, S., Hamel, E., Banner, E.J., Kharlamova, A., Hempel, J., Gupton, J.T., Brown, M.L. Mol. Pharmacol. (2007)
- Microtubule-stabilizing agents based on designed laulimalide analogues. Mooberry, S.L., Randall-Hlubek, D.A., Leal, R.M., Hegde, S.G., Hubbard, R.D., Zhang, L., Wender, P.A. Proc. Natl. Acad. Sci. U.S.A. (2004)
- The molecular pharmacology of symplostatin 1: a new antimitotic dolastatin 10 analog. Mooberry, S.L., Leal, R.M., Tinley, T.L., Luesch, H., Moore, R.E., Corbett, T.H. Int. J. Cancer (2003)
- Mechanism of action of 2-methoxyestradiol: new developments. Mooberry, S.L. Drug Resist. Updat. (2003)